SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $228,000 | +1.3% | 6,305 | 0.0% | 0.02% | -11.8% |
| Q4 2022 | $225,000 | +5.1% | 6,305 | -0.2% | 0.02% | -39.3% |
| Q3 2022 | $214,000 | -21.3% | 6,319 | -38.0% | 0.03% | -90.8% |
| Q3 2021 | $272,000 | -13.4% | 10,188 | 0.0% | 0.30% | -14.6% |
| Q2 2021 | $314,000 | +17.6% | 10,188 | 0.0% | 0.36% | +22.3% |
| Q1 2021 | $267,000 | -47.7% | 10,188 | -49.8% | 0.29% | -26.3% |
| Q4 2020 | $511,000 | -9.2% | 20,307 | -24.9% | 0.40% | +4.8% |
| Q3 2020 | $563,000 | -12.3% | 27,039 | -24.2% | 0.38% | -6.0% |
| Q1 2020 | $642,000 | +61.3% | 35,663 | +146.3% | 0.40% | +49.6% |
| Q3 2019 | $398,000 | – | 14,482 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |